Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2011.07.06, GB 201111500
2011.07.06, GB 201111503
2011.07.06, GB 201111505
2011.07.06, GB 201111509
ABDALLAH B M ET AL: "Human mesenchymal stem cells: from basic biology to clinical applications", GENE THERAPY, NATURE PUBLISHING GROUP, GB, vol. 15, no. 2, 1 January 2008 (2008-01-01), pages 109-116, XP002505627, ISSN: 0969-7128, DOI: 10.1038/SJ.GT.3303067 (B1)
YAOJIONG WU ET AL: "The Role of Chemokines in Mesenchymal Stem Cell Homing to Myocardium", STEM CELL REVIEWS AND REPORTS, HUMANA PRESS INC, NEW YORK, vol. 8, no. 1, 25 June 2011 (2011-06-25), pages 243-250, XP035019891, ISSN: 1558-6804, DOI: 10.1007/S12015-011-9293-Z (B1)
ANDRIELLE CASTILHO-FERNANDES ET AL: "Human hepatic stellate cell line (LX-2) exhibits characteristics of bone marrow-derived mesenchymal stem cells", EXPERIMENTAL AND MOLECULAR PATHOLOGY, vol. 91, no. 3, 9 September 2011 (2011-09-09), pages 664-672, XP028111727, ISSN: 0014-4800, DOI: 10.1016/J.YEXMP.2011.09.002 [retrieved on 2011-09-09] (B1)
BASEM M. ABDALLAH ET AL: "The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: Current status and future perspectives", JOURNAL OF CELLULAR PHYSIOLOGY, vol. 218, no. 1, 1 January 2009 (2009-01-01), pages 9-12, XP055056394, ISSN: 0021-9541, DOI: 10.1002/jcp.21572 (B1)
BUEHRING HANS-JOERG ET AL: "Novel markers for the prospective isolation of human MSC", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, WILEY-BLACKWELL PUBLISHING, INC, US, 16 September 2006 (2006-09-16), pages 262-271, XP009109140, ISSN: 0077-8923 (B1)
CARRANCIO S ET AL: "Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification", EXPERIMENTAL HEMATOLOGY, ELSEVIER INC, US, vol. 36, no. 8, 1 August 2008 (2008-08-01) , pages 1014-1021, XP022940505, ISSN: 0301-472X, DOI: 10.1016/J.EXPHEM.2008.03.012 [retrieved on 2008-05-12] (B1)
CATHERINE M KOLF ET AL: "Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation", ARTHRITIS RESEARCH AND THERAPY, BIOMED CENTRAL, LONDON, GB, vol. 9, no. 1, 19 February 2007 (2007-02-19), pages 204-1, XP008146968, ISSN: 1478-6354, DOI: 10.1186/AR2116 (B1)
DANUTA JAROCHA ET AL: "Adventage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells.", FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, vol. 46, no. 3, 6 December 2008 (2008-12-06), XP055052371, ISSN: 0239-8508, DOI: 10.2478/v10042-008-0046-z (B1)
DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; October 2010 (2010-10), LIU QUAN-HUA ET AL: "[Are CD133 and CD271 useful in positive selection to enrich umbilical cord blood mesenchymal stem cells?].", XP002693611, Database accession no. NLM21129278 & LIU QUAN-HUA ET AL: "[Are CD133 and CD271 useful in positive selection to enrich umbilical cord blood mesenchymal stem cells?].", ZHONGGUO SHI YAN XUE YE XUE ZA ZHI / ZHONGGUO BING LI SHENG LI XUE HUI = JOURNAL OF EXPERIMENTAL HEMATOLOGY / CHINESE ASSOCIATION OF PATHOPHYSIOLOGY OCT 2010, vol. 18, no. 5, October 2010 (2010-10), pages 1286-1291, ISSN: 1009-2137 (B1)
GISELLE CHAMBERLAIN ET AL: "Murine Mesenchymal Stem Cells Exhibit a Restricted Repertoire of Functional Chemokine Receptors: Comparison with Human", PLOS ONE, PUBLIC LIBRARY OF SCIENCE, US, vol. 3, no. 8, 1 August 2008 (2008-08-01), pages e2934.1-e2934.6, XP002622569, ISSN: 1932-6203, DOI: 10.1371/JOURNAL.PONE.0002934 (B1)
HATIM HEMEDA ET AL: "Interferon-[gamma] and Tumor Necrosis Factor-[alpha] Differentially Affect Cytokine Expression and Migration Properties of Mesenchymal Stem Cells", STEM CELLS AND DEVELOPMENT, vol. 19, no. 5, 1 May 2010 (2010-05-01), pages 693-706, XP055056178, ISSN: 1547-3287, DOI: 10.1089/scd.2009.0365 (B1)
HOLZWARTH CHRISTINA ET AL: "Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells", BMC CELL BIOLOGY, BIOMED CENTRAL, LONDON, GB, vol. 11, no. 1, 28 January 2010 (2010-01-28), page 11, XP021065781, ISSN: 1471-2121 (B1)
LIU H ET AL: "Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 401, no. 4, 29 October 2010 (2010-10-29), pages 509-515, XP027567795, ISSN: 0006-291X, DOI: 10.1016/J.BBRC.2010.09.076 [retrieved on 2010-09-24] (B1)
MARIA ESTER BERNARDO ET AL: "Mesenchymal stromal cells", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, WILEY-BLACKWELL PUBLISHING, INC, US, vol. 1176, 1 September 2009 (2009-09-01), pages 101-117, XP008156034, ISSN: 0077-8923, DOI: 10.1111/J.1749-6632.2009.04607.X [retrieved on 2009-09-25] (B1)
NAGHMEH AHMADIAN KIA ET AL: "Comparative Analysis of Chemokine Receptor's Expression in Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue", JOURNAL OF MOLECULAR NEUROSCIENCE, HUMANA PRESS INC, NEW YORK, vol. 44, no. 3, 12 October 2010 (2010-10-12), pages 178-185, XP019912023, ISSN: 1559-1166, DOI: 10.1007/S12031-010-9446-6 (B1)
WAGNER W ET AL: "Mesenchymal stem cell preparations--comparing apples and oranges", STEM CELL REVIEWS, HUMANA PRESS INC, US, vol. 3, no. 4, 1 December 2007 (2007-12-01), pages 239-248, XP002545736, ISSN: 1550-8943, DOI: 10.1007/S12015-007-9001-1 [retrieved on 2007-09-18] (B1)
WO-A1-2007/058404 (B1)
WO-A1-2010/021412 (B1)
WO-A2-2009/069991 (B1)
ADRIANA LÓPEZ PONTE ET AL: "The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities", STEM CELLS, vol. 25, no. 7, 1 July 2007 (2007-07-01), pages 1737-1745, XP55050706, ISSN: 1066-5099, DOI: 10.1634/stemcells.2007-0054 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210)
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 13. avg. år (EP) | 2024.07.09 | 5460 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 12. avg. år (EP) | 2023.07.12 | 3850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2022.07.08 | 3500 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 10. avg. år (EP) | 2021.07.09 | 3200 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2020.07.10 | 2850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2019.07.09 | 2550 | CPA GLOBAL LIMITED | Betalt og godkjent |
31811796 expand_more expand_less | 2018.07.26 | 5500 | ZACCO NORWAY AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|
||||
Årsavgift 7. avg. år (EP) | 2018.07.10 | 2200 | CPA GLOBAL LIMITED | Betalt og godkjent |